Listar por tema "Inflammation"
Mostrando ítems 1-20 de 51
-
Article
-
Review
A review of the pharmacological and therapeutic effects of auraptene (2020)
(Blackwell Publishing Inc., 2019) -
Review
Acquisition, maintenance and relapse-like alcohol drinking: Lessons from the uchb rat line (2020)
(Frontiers Media S.A., 2017) -
Article
Activation of melanocortin-4 receptor by a synthetic agonist inhibits ethanolinduced neuroinflammation in rats (2020)
(Bentham Science Publishers, 2019) -
Article
Activation of the nlrp3 inflammasome increases the il-1β level and decreases glut4 translocation in skeletal muscle during insulin resistance (2021)
(MDPI, 2021-10)Low-grade chronic inflammation plays a pivotal role in the pathogenesis of insulin resistance (IR), and skeletal muscle has a central role in this condition. NLRP3 inflammasome activation pathways promote low-grade chronic ... -
Article
Adolescent Binge Alcohol Exposure Affects the Brain Function Through Mitochondrial Impairment (2020)
(Humana Press Inc., 2018) -
Short Survey
-
Article
Caffeine intake may modulate inflammation markers in trained rats (2020)
(MDPI AG, 2014) -
Article
-
Article
Circulating inflammatory miRNA signature in response to different doses of aerobic exercise (2020)
(American Physiological Society, 2015) -
Review
Connexins in astrocyte migration (2020)
(Frontiers Media S.A., 2020) -
Article
-
Article
Correlation between inflammatory markers with physical function and body composition in community older adults: a cross-sectional study (2024)
(Sociedad espanola de dietetica, 2024)Introduction: Aging is associated with various chronic diseases that cause systemic inflammation, characterized by an increase in blood levels of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α). Physical ... -
Review
Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder (2020)
(NLM (Medline), 2018) -
Review
Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder (2020)
(Humana Press Inc., 2018) -
Review
Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets (2020)
(Wiley-Liss Inc., 2019) -
Article
-
Article
-
Article
-
Article